Bio-Techne Corp. (TECH)
Bio-Techne Corp. (TECH) is a global leader in the development, manufacturing, and distribution of biotechnology and pharmaceutical products. The company specializes in proteins, antibodies, and reagents used in scientific research, clinical diagnostics, and biopharmaceutical development. Founded in 1980, Bio-Techne serves customers across life sciences, healthcare, and biotech industries, providing innovative solutions to advance scientific discovery and improve healthcare outcomes.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 29, 2025 | $0.08 | 2025-08-18 | 2025-08-18 |
| May 30, 2025 | $0.08 | 2025-05-19 | 2025-05-19 |
| February 28, 2025 | $0.08 | 2025-02-14 | 2025-02-17 |
| November 22, 2024 | $0.08 | 2024-11-08 | 2024-11-11 |
| August 30, 2024 | $0.08 | 2024-08-19 | 2024-08-19 |
Dividends Summary
- Bio-Techne Corp. has issued 68 dividend payments over the past 17 years
- The most recent dividend was paid 54 days ago, on August 29, 2025
- The highest dividend payed out to investors during this period was $0.32 per share
- The average dividend paid during this period was $0.27 per share.
Company News
MDxHealth has completed the acquisition of Exosome Diagnostics from Bio-Techne for $15 million, which includes the ExoDx Prostate test and related assets, with payments structured over four years.
The global recombinant human hair keratin protein market is experiencing rapid growth, driven by increasing demand in biomedical and cosmetic applications, with North America leading and Asia-Pacific showing the fastest growth potential by 2034.
Bio-Techne reported Q4 fiscal 2025 earnings with modest revenue beat and non-GAAP EPS growth, but faced challenges including an $83.1 million impairment loss from divesting Exosome Diagnostics and margin pressures in its Diagnostics segment.
The S&P 500 is up for the fourth consecutive session. While many stocks have powered the ETF, we have highlighted five that have led the way higher.
